SCHEMBL2637557

SCHEMBL2637557

COc1cc(/C=C/c2ccc(NC(=O)OC(C)(C)C)cc2)ccc1C(OC)OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.45
HDAC1 Q13547 3/20 0.42
HDAC3 O15379 2/20 0.42
HDAC2 Q92769 2/20 0.42
HDAC8 Q9BY41 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
HDAC4 P56524 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
KDM1A O60341 3/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
STAT1 P42224 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2637559 1.00 KDM4E (0.45) KDM4EHDAC1HDAC3HDAC2HDAC8
SCHEMBL28048505 0.84 KMT2A (0.47) KDM4EHDAC1KDM1AALDH1A1KMT2A
SCHEMBL2636843 0.81 KDM4E (0.46) KDM4EHDAC1HDAC3HDAC2HDAC8
SCHEMBL2636844 0.81 KDM4E (0.46) KDM4EHDAC1HDAC3HDAC2HDAC8
SCHEMBL1974701 0.78 MAPT (0.48) KDM4EHDAC1HDAC3HDAC2HDAC8
SCHEMBL1974700 0.78 MAPT (0.48) KDM4EHDAC1HDAC3HDAC2HDAC8
SCHEMBL2636400 0.76 ACHE (0.48) KDM4EHDAC1HDAC3HDAC2HDAC8
SCHEMBL2636189 0.76 ACHE (0.48) KDM4EHDAC1HDAC3HDAC2HDAC8
SCHEMBL2636406 0.75 CXCL12 (0.53) KDM4EALDH1A1GAAKMT2AMEN1
SCHEMBL2636403 0.75 CXCL12 (0.53) KDM4EALDH1A1GAAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2437792-B1 IMAGING OF MYELIN BASIC PROTEIN GEN ELECTRIC (US) 2015-10-21 EP disclosed
US-8617515-B2 Imaging of myelin basic protein GENERAL ELECTRIC COMPANY (US) 2013-12-31 US disclosed
EP-2437792-A2 IMAGING OF MYELIN BASIC PROTEIN General Electric Company (US) 2012-04-11 EP disclosed
WO-2010141704-A2 IMAGING OF MYELIN BASIC PROTEIN GENERAL ELECTRIC COMPANY (US) 2010-12-09 WO disclosed
US-20100310457-A1 IMAGING OF MYELIN BASIC PROTEIN GENERAL ELECTRIC COMPANY (US) 2010-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100310457-A1 IMAGING OF MYELIN BASIC PROTEIN MAG, PMP22, MYT1 KDM4E 3377/4885HDAC1 4121/4885HDAC3 4434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.